Bio-Path Holdings, Inc.
News
Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment Conference
Globe Newswire HOUSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize liposomal delivery and antisense technology to...\n more…
Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A's Compelling Potential as Treatment for Advanced Solid Tumors
Globe Newswire First Solid Tumor Patient Treated with Second, Higher Dose in Phase 1/1b BP1001-A Clinical Trial Experienced Tumor Reduction and Continued Stable Disease Reports Continued Patient Progress from...\n more…
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Expected to Post Q3 2024 Earnings of ($1.02) Per Share
Zolmax Bio-Path Holdings, Inc. (NASDAQ:BPTH - Free Report) - Roth Capital lowered their Q3 2024 earnings per share estimates for Bio-Path in a research report issued on Thursday, August 15th. Roth...\n more…
Bio-Path Holdings, Inc. to Post Q3 2024 Earnings of ($1.02) Per Share, Roth Capital Forecasts (NASDAQ:BPTH)
Ticker Report Bio-Path Holdings, Inc. (NASDAQ:BPTH - Free Report) - Stock analysts at Roth Capital reduced their Q3 2024 earnings per share estimates for Bio-Path in a report issued on Thursday, August 15th. Roth...\n more…
Bio-Path Holdings Reports Second Quarter 2024 Financial Results
Globe Newswire Conference Call to be Held Today at 8:30 A.M. ETHOUSTON, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize...\n more…
BPTH Stock Earnings: Bio-Path Holdings Beats EPS for Q2 2024
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nBPTH stock results show that Bio-Path Holdings beat analyst estimates for earnings per share the second quarter of 2024.\nThe post BPTH...\n more…